Anvar Soleimani

732 total citations
22 papers, 536 citations indexed

About

Anvar Soleimani is a scholar working on Molecular Biology, Oncology and Physiology. According to data from OpenAlex, Anvar Soleimani has authored 22 papers receiving a total of 536 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 6 papers in Oncology and 5 papers in Physiology. Recurrent topics in Anvar Soleimani's work include Adenosine and Purinergic Signaling (5 papers), RNA Interference and Gene Delivery (4 papers) and Peptidase Inhibition and Analysis (3 papers). Anvar Soleimani is often cited by papers focused on Adenosine and Purinergic Signaling (5 papers), RNA Interference and Gene Delivery (4 papers) and Peptidase Inhibition and Analysis (3 papers). Anvar Soleimani collaborates with scholars based in Iran, Iraq and Germany. Anvar Soleimani's co-authors include Mohammad Soukhtanloo, Arash Soltani, Mostafa Karimi Roshan, Kolsoum Rezaie Kahkhaie, Amir R. Afshari, Farshad Mirzavi, Mahmoud Reza Jaafari, Roghayyeh Vakili‐Ghartavol, Mehdi Barati and Jamshid Gholizadeh Navashenaq and has published in prestigious journals such as SHILAP Revista de lepidopterología, Scientific Reports and International Journal of Pharmaceutics.

In The Last Decade

Anvar Soleimani

21 papers receiving 528 citations

Peers

Anvar Soleimani

ONCOL

IMMUN

Erica Miraglia Italy

Shuanghong Yin China

Liqun Zhao China

Li‐Min Xie China

Aline Beckenkamp Brazil

Ana Carolina Martínez‐Torres Mexico

Pinelopi Samara Greece

Xiuhua Wu China

Meena Prasad United States

Erica Miraglia Italy

Anvar Soleimani

233 ×1.0

112 ×1.0

ONCOL

77 ×1.0

73 ×0.9

IMMUN

85 ×1.2

Citations per year, relative to Anvar Soleimani Anvar Soleimani (= 1×) peers Erica Miraglia

Countries citing papers authored by Anvar Soleimani

Since Specialization

Citations

This map shows the geographic impact of Anvar Soleimani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anvar Soleimani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anvar Soleimani more than expected).

Fields of papers citing papers by Anvar Soleimani

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anvar Soleimani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anvar Soleimani. The network helps show where Anvar Soleimani may publish in the future.

Co-authorship network of co-authors of Anvar Soleimani

This figure shows the co-authorship network connecting the top 25 collaborators of Anvar Soleimani. A scholar is included among the top collaborators of Anvar Soleimani based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anvar Soleimani. Anvar Soleimani is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Soleimani, Anvar, et al.. (2025). Epigenetic and post-translational modifications in ferroptosis regulation and hepatocellular carcinoma: New frontiers in therapeutic targeting. Pathology - Research and Practice. 270. 155991–155991. 1 indexed citations

Soleimani, Anvar, et al.. (2025). MAPK signaling mediates tamoxifen resistance in estrogen receptor-positive breast cancer. Molecular and Cellular Biochemistry. 480(9). 4973–4989. 1 indexed citations

Haftcheshmeh, Saeed Mohammadian, et al.. (2025). Berberine as a natural immunomodulator of B lymphocytes. Inflammopharmacology. 33(8). 4191–4204. 2 indexed citations

Moradi, Reza, et al.. (2024). The protection role of human growth hormone on skin cells following ultraviolet B exposure. Journal of Photochemistry and Photobiology B Biology. 257. 112961–112961. 2 indexed citations

Mirzavi, Farshad, et al.. (2023). Nanoparticles-based therapeutics for the management of bacterial infections: A special emphasis on FDA approved products and clinical trials. European Journal of Pharmaceutical Sciences. 188. 106515–106515. 76 indexed citations

Soleimani, Anvar, et al.. (2023). Mutational landscape of phenylketonuria in Iran. Journal of Cellular and Molecular Medicine. 27(17). 2457–2466. 3 indexed citations

Soleimani, Anvar, Farshad Mirzavi, Sara Nikoofal‐Sahlabadi, et al.. (2022). CD73 downregulation by EGFR-targeted liposomal CD73 siRNA potentiates antitumor effect of liposomal doxorubicin in 4T1 tumor-bearing mice. Scientific Reports. 12(1). 10423–10423. 11 indexed citations

Mirzavi, Farshad, Mehdi Barati, Anvar Soleimani, et al.. (2021). A review on liposome-based therapeutic approaches against malignant melanoma. International Journal of Pharmaceutics. 599. 120413–120413. 52 indexed citations

Barati, Mehdi, Farshad Mirzavi, Amin Reza Nikpoor, et al.. (2021). Enhanced antitumor immune response in melanoma tumor model by anti-PD-1 small interference RNA encapsulated in nanoliposomes. Cancer Gene Therapy. 29(6). 814–824. 23 indexed citations

10.

Mashayekhi, Kazem, Reza Falak, Saeed Mohammadian Haftcheshmeh, et al.. (2020). Production and Characterization of Monoclonal Antibody against Vit v1: A Grape Allergen Belonging to Lipid Transfer Protein Family. Iranian Journal of Allergy Asthma and Immunology. 19(2). 139–148. 2 indexed citations

11.

Soleimani, Anvar, Farshad Mirzavi, Parvin Zamani, et al.. (2020). The therapeutic potential of targeting CD73 and CD73-derived adenosine in melanoma. Biochimie. 176. 21–30. 19 indexed citations

12.

Hashemy, Seyed Isaac, et al.. (2020). Investigating the Diagnostic Value of Serum Calprotectin Level in Patients With Acute Appendicitis. SHILAP Revista de lepidopterología.

13.

Safarian, Mohammad, Mojtaba Shafiee, Azita Ganji, et al.. (2019). Effect of diet-induced weight loss on cytokeratin-18 levels in overweight and obese patients with liver fibrosis. Diabetes & Metabolic Syndrome Clinical Research & Reviews. 13(2). 989–994. 8 indexed citations

14.

Roshan, Mostafa Karimi, Arash Soltani, Anvar Soleimani, et al.. (2019). Role of AKT and mTOR signaling pathways in the induction of epithelial-mesenchymal transition (EMT) process. Biochimie. 165. 229–234. 190 indexed citations

15.

Ghaderi, Amir, Hamid Reza Banafshe, Anvar Soleimani, et al.. (2019). Clinical and metabolic responses to crocin in patients under methadone maintenance treatment: A randomized clinical trial. Phytotherapy Research. 33(10). 2714–2725. 31 indexed citations

16.

Soleimani, Anvar, Eskandar Taghizadeh, Yousef Amini, et al.. (2019). CD73; a key ectonucleotidase in the development of breast cancer: Recent advances and perspectives. Journal of Cellular Physiology. 234(9). 14622–14632. 19 indexed citations

17.

Soltani, Arash, Seyed Isaac Hashemy, Farnaz Zahedi Avval, et al.. (2018). Molecular targeting for treatment of human T-lymphotropic virus type 1 infection. Biomedicine & Pharmacotherapy. 109. 770–778. 27 indexed citations

18.

Soltani, Arash, Arash Salmaninejad, Mohammad Jalili‐Nik, et al.. (2018). 5′‐Adenosine monophosphate‐activated protein kinase: A potential target for disease prevention by curcumin. Journal of Cellular Physiology. 234(3). 2241–2251. 27 indexed citations

19.

Soleimani, Anvar, Amirhossein Bahreyni, Mostafa Karimi Roshan, et al.. (2018). Therapeutic potency of pharmacological adenosine receptors agonist/antagonist on cancer cell apoptosis in tumor microenvironment, current status, and perspectives. Journal of Cellular Physiology. 234(3). 2329–2336. 23 indexed citations

20.

Soleimani, Anvar, et al.. (2015). Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand Gene Polymorphisms and Hepatitis B Virus Infection. Jundishapur Journal of Microbiology. 8(11). e23578–e23578. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact